Colitis

Also known as: Colitis (NOS) / Colitis NOS

DrugDrug NameDrug Description
DB01190ClindamycinClindamycin is a semisynthetic lincosamide antibiotic that has largely replaced lincomycin due to an improved side effect profile. Clindamycin inhibits bacterial protein synthesis by binding to bacterial 50S ribosomal subunits. It may be bacteriostatic or bactericidal depending on the organism and drug concentration.
DrugDrug NamePhaseStatusCount
DB03756Doconexent1Completed1
DB13961Fish oil1Completed1
DB01004Ganciclovir1Completed1
DB00142Glutamic Acid1Completed1
DB00051Adalimumab2Withdrawn1
DB00065Infliximab2Withdrawn1
DB01033Mercaptopurine2Withdrawn1
DB00244Mesalazine2Withdrawn1
DB00864Tacrolimus2Withdrawn1
DB09033Vedolizumab2Not Yet Recruiting1
DB05679Ustekinumab3Active Not Recruiting1
DB06674Golimumab4Recruiting1
DB01294Bismuth SubsalicylateNot AvailableTerminated1
DB01222BudesonideNot AvailableTerminated1
DB01004GanciclovirNot AvailableCompleted1
DB11097Plantago seedNot AvailableTerminated1
DB09311PolycarbophilNot AvailableTerminated1
DB09153Sodium ChlorideNot AvailableTerminated1
DB06273TocilizumabNot AvailableNot Yet Recruiting1
DB00512VancomycinNot AvailableTerminated1